RYJ:NYE-Invesco Raymond James SB-1 Equity ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 71.858

Change

0.00 (0.00)%

Market Cap

N/A

Volume

678.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.89 (-0.76%)

USD 14.94B
VOT Vanguard Mid-Cap Growth Index ..

-1.99 (-0.82%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

-0.67 (-0.73%)

USD 9.84B
XMMO Invesco S&P MidCap Momentum ET..

-0.48 (-0.40%)

USD 2.43B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-0.70 (-0.61%)

USD 1.08B
ETHO Amplify ETF Trust

-0.88 (-1.47%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

-0.35 (-0.51%)

USD 0.17B
IPO Renaissance IPO ETF

-0.92 (-2.15%)

USD 0.15B
BFOR Barron's 400 ETF

-0.49 (-0.68%)

USD 0.15B
PEXL Pacer US Export Leaders ETF

-0.52 (-1.03%)

USD 0.07B

ETFs Containing RYJ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.29% 88% B+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.29% 88% B+ 68% D+
Trailing 12 Months  
Capital Gain 33.39% 83% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.39% 83% B 72% C
Trailing 5 Years  
Capital Gain 74.41% 67% D+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.41% 67% D+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike